Brief: India's Caplin Point Laboratories Sept-Quarter Consol Net Profit Rises
02/11/2021 08:24
Nov 2 (Reuters) - Caplin Point Laboratories Ltd CAPL.NS :
* SEPT-QUARTER CONSOL NET PROFIT 749.8 MILLION RUPEES VERSUS
568.9
MILLION RUPEES YEAR AGO
* CAPLIN POINT LABORATORIES SEPT-QUARTER CONSOL REVENUE FROM
OPERATIONS 3.04 BILLION RUPEES VERSUS 2.68 BILLION RUPEES YEAR
AGO
Source text for Eikon: ID:
Further company coverage: CAPL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Caplin Point Laboratories
See all newsBrief: Caplin Point Laboratories Says US FDA Completes Unannounced Inspection Of Caplin Steriles Gummidipoondi Facility
Brief: Caplin Point Laboratories March-Quarter Consol Net Profit 1.7 Bln Rupees
Brief: Caplin Point Laboratories Unit Receives Final USFDA Approval For ANDA Potassium Phosphates Injection
Brief: Caplin Point Laboratories Says Unit Receives USFDA Approval For Sodium Phosphates Injection
Brief: Caplin Point Laboratories Dec-Quarter Consol Net Profit 1.64 Billion Rupees